MAIA Biotechnology, Inc. MAIA
1.11 USD +0.03 (+2.78%)
Nov 4, 2026, 2:50 PM EST
1.10 Day range 1.14
0.87 52-week range 3.19
- YTD
- -27.45%
- 1 year
- +0.91%
Financial health
Altman Z-Score
-2.72 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 2
Valuation
P/E -2.2×
FY 2019 5y median -2.1× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 20.7×
FY 2019 5y median 12.1× FY 2025
P/FCF -2.6×
FY 2019 5y median -2.7× FY 2025
EV/EBITDA 384×
FY 2019 5y median -1.4× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -38.4%
FY 2019 5y median -37.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -942.7%
FY 2019 5y median -639.8% FY 2025
ROIC -627.4%
FY 2019 5y median -268.1% FY 2025
ROA -230.8%
FY 2019 5y median -229.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -43.1%
FY 2019 FY 2025
EPS (diluted) 33.3%
FY 2019 FY 2025
Free Cash Flow -20.0%
FY 2019 FY 2025
Financial Health
Current Ratio 1.7×
FY 2019 5y median 2.7× FY 2025
Quick Ratio 1.7×
FY 2019 5y median 2.7× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 387×
FY 2019 5y median 0.7× FY 2025
Interest Coverage 0.0×
FY 2019 5y median -9.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31